No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Express News | Sarepta Therapeutics Inc : Leerink Partners Cuts Target Price to $200 From $210
A Quick Look at Today's Ratings for Sarepta Therapeutics(SRPT.US), With a Forecast Between $75 to $203
Sarepta Therapeutics Price Target Maintained With a $75.00/Share by HC Wainwright & Co.
Temporary Revenue Surge and Market Penetration Concerns Lead to Sell Rating for Sarepta Therapeutics
Sarepta, Biogen Drugs With Accelerated Approval Under Fire in FDA Report
Needham Reiterates Buy on Sarepta Therapeutics, Maintains $202 Price Target